Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
11092 | 1008 | 36.3 | 72% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
176 | 3 | DIABETES CARE//ENDOCRINOLOGY & METABOLISM//TYPE 2 DIABETES | 58057 |
1552 | 2 | INSULIN RECEPTOR//INSULIN DEGRADING ENZYME//INOSITOL PHOSPHOGLYCAN | 7396 |
11092 | 1 | INOSITOL PHOSPHOGLYCAN//D CHIRO INOSITOL//CHIRO INOSITOL | 1008 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | INOSITOL PHOSPHOGLYCAN | authKW | 875414 | 3% | 85% | 34 |
2 | D CHIRO INOSITOL | authKW | 545658 | 3% | 51% | 35 |
3 | CHIRO INOSITOL | authKW | 276937 | 2% | 57% | 16 |
4 | MYO INOSITOL | authKW | 231862 | 7% | 10% | 74 |
5 | INSULIN MEDIATOR | authKW | 223052 | 1% | 82% | 9 |
6 | INOSITOLPHOSPHATE GLYCAN | authKW | 185534 | 1% | 88% | 7 |
7 | PROSTAGLANDYLINOSITOL CYCLIC PHOSPHATE | authKW | 151457 | 0% | 100% | 5 |
8 | PINITOL | authKW | 140860 | 2% | 23% | 20 |
9 | MICHAEL CHEM | address | 96931 | 0% | 80% | 4 |
10 | SCI PEDIAT ADOLESCENZA | address | 90874 | 0% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Endocrinology & Metabolism | 3911 | 25% | 0% | 248 |
2 | Biochemistry & Molecular Biology | 2645 | 44% | 0% | 439 |
3 | Biophysics | 2005 | 17% | 0% | 170 |
4 | Cell Biology | 533 | 13% | 0% | 136 |
5 | Obstetrics & Gynecology | 297 | 6% | 0% | 60 |
6 | Reproductive Biology | 211 | 3% | 0% | 32 |
7 | Medicine, Research & Experimental | 92 | 5% | 0% | 48 |
8 | Physiology | 38 | 3% | 0% | 32 |
9 | Nutrition & Dietetics | 34 | 2% | 0% | 22 |
10 | Pharmacology & Pharmacy | 33 | 6% | 0% | 62 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MICHAEL CHEM | 96931 | 0% | 80% | 4 |
2 | SCI PEDIAT ADOLESCENZA | 90874 | 0% | 100% | 3 |
3 | GRP CARBOHIDRATOS | 78315 | 1% | 17% | 15 |
4 | JAMES A HALEY VET HOSP MED BIOCHEM | 60583 | 0% | 100% | 2 |
5 | MOTOR ACT METAB REHABIL DIABET CRAMD | 60583 | 0% | 100% | 2 |
6 | HUMAN PATHOL ADULTHOOD CHILDHOOD G BAR I | 37857 | 0% | 25% | 5 |
7 | 13000 BRUCE DOWNS BLVD | 30291 | 0% | 100% | 1 |
8 | 414 IMMUNOL ONCOL | 30291 | 0% | 100% | 1 |
9 | AGR SCI TEHCNOL | 30291 | 0% | 100% | 1 |
10 | AGUNCO | 30291 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | INTERNATIONAL JOURNAL OF ENDOCRINOLOGY | 10116 | 2% | 2% | 19 |
2 | GYNECOLOGICAL ENDOCRINOLOGY | 4876 | 2% | 1% | 22 |
3 | ENDOCRINOLOGY | 2643 | 5% | 0% | 47 |
4 | EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES | 2249 | 2% | 0% | 16 |
5 | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 2244 | 7% | 0% | 72 |
6 | CELLULAR SIGNALLING | 2226 | 2% | 0% | 18 |
7 | JOURNAL OF REPRODUCTIVE IMMUNOLOGY | 1828 | 1% | 1% | 11 |
8 | BIOCHEMICAL JOURNAL | 1605 | 4% | 0% | 40 |
9 | ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS | 1456 | 3% | 0% | 29 |
10 | METABOLISM-CLINICAL AND EXPERIMENTAL | 1205 | 2% | 0% | 19 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INOSITOL PHOSPHOGLYCAN | 875414 | 3% | 85% | 34 | Search INOSITOL+PHOSPHOGLYCAN | Search INOSITOL+PHOSPHOGLYCAN |
2 | D CHIRO INOSITOL | 545658 | 3% | 51% | 35 | Search D+CHIRO+INOSITOL | Search D+CHIRO+INOSITOL |
3 | CHIRO INOSITOL | 276937 | 2% | 57% | 16 | Search CHIRO+INOSITOL | Search CHIRO+INOSITOL |
4 | MYO INOSITOL | 231862 | 7% | 10% | 74 | Search MYO+INOSITOL | Search MYO+INOSITOL |
5 | INSULIN MEDIATOR | 223052 | 1% | 82% | 9 | Search INSULIN+MEDIATOR | Search INSULIN+MEDIATOR |
6 | INOSITOLPHOSPHATE GLYCAN | 185534 | 1% | 88% | 7 | Search INOSITOLPHOSPHATE+GLYCAN | Search INOSITOLPHOSPHATE+GLYCAN |
7 | PROSTAGLANDYLINOSITOL CYCLIC PHOSPHATE | 151457 | 0% | 100% | 5 | Search PROSTAGLANDYLINOSITOL+CYCLIC+PHOSPHATE | Search PROSTAGLANDYLINOSITOL+CYCLIC+PHOSPHATE |
8 | PINITOL | 140860 | 2% | 23% | 20 | Search PINITOL | Search PINITOL |
9 | D PINITOL | 85511 | 1% | 24% | 12 | Search D+PINITOL | Search D+PINITOL |
10 | CYCLIC AMP ANTAGONIST | 68154 | 0% | 75% | 3 | Search CYCLIC+AMP+ANTAGONIST | Search CYCLIC+AMP+ANTAGONIST |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | JONES, DR , VARELA-NIETO, I , (1998) THE ROLE OF GLYCOSYL-PHOSPHATIDYLINOSITOL IN SIGNAL TRANSDUCTION.INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY. VOL. 30. ISSUE 3. P. 313 -326 | 80 | 71% | 73 |
2 | VARELANIETO, I , LEON, Y , CARO, HN , (1996) CELL SIGNALLING BY INOSITOL PHOSPHOGLYCANS FROM DIFFERENT SPECIES.COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY. VOL. 115. ISSUE 2. P. 223 -241 | 103 | 56% | 68 |
3 | CROZE, ML , SOULAGE, CO , (2013) POTENTIAL ROLE AND THERAPEUTIC INTERESTS OF MYO-INOSITOL IN METABOLIC DISEASES.BIOCHIMIE. VOL. 95. ISSUE 10. P. 1811-1827 | 47 | 59% | 48 |
4 | THOMAS, MP , MILLS, SJ , POTTER, BVL , (2016) THE "OTHER" INOSITOLS AND THEIR PHOSPHATES: SYNTHESIS, BIOLOGY, AND MEDICINE (WITH RECENT ADVANCES IN MYO-INOSITOL CHEMISTRY).ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. VOL. 55. ISSUE 5. P. 1614 -1650 | 73 | 26% | 7 |
5 | GARG, D , TAL, R , (2016) INOSITOL TREATMENT AND ART OUTCOMES IN WOMEN WITH PCOS.INTERNATIONAL JOURNAL OF ENDOCRINOLOGY. VOL. . ISSUE . P. - | 42 | 66% | 0 |
6 | MILEWSKA, EM , CZYZYK, A , MECZEKALSKI, B , GENAZZANI, AD , (2016) INOSITOL AND HUMAN REPRODUCTION. FROM CELLULAR METABOLISM TO CLINICAL USE.GYNECOLOGICAL ENDOCRINOLOGY. VOL. 32. ISSUE 9. P. 690 -695 | 39 | 68% | 0 |
7 | STRALFORS, P , (1997) INSULIN SECOND MESSENGERS.BIOESSAYS. VOL. 19. ISSUE 4. P. 327-335 | 54 | 75% | 52 |
8 | BEVILACQUA, A , BIZZARRI, M , (2016) PHYSIOLOGICAL ROLE AND CLINICAL UTILITY OF INOSITOLS IN POLYCYSTIC OVARY SYNDROME.BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY. VOL. 37. ISSUE . P. 129 -139 | 44 | 53% | 1 |
9 | PAUL, C , LAGANA, AS , MANIGLIO, P , TRIOLO, O , BRADY, DM , (2016) INOSITOL'S AND OTHER NUTRACEUTICALS' SYNERGISTIC ACTIONS COUNTERACT INSULIN RESISTANCE IN POLYCYSTIC OVARIAN SYNDROME AND METABOLIC SYNDROME: STATE-OF-THE-ART AND FUTURE PERSPECTIVES.GYNECOLOGICAL ENDOCRINOLOGY. VOL. 32. ISSUE 6. P. 431 -438 | 36 | 68% | 0 |
10 | FARESE, RV , STANDAERT, ML , ARNOLD, T , YU, BZ , ISHIZUKA, T , HOFFMAN, J , VILA, M , COOPER, DR , (1992) THE ROLE OF PROTEIN-KINASE-C IN INSULIN ACTION.CELLULAR SIGNALLING. VOL. 4. ISSUE 2. P. 133-143 | 58 | 78% | 44 |
Classes with closest relation at Level 1 |